Dr. Claudio Andaloro is MD at Department of Surgery, Otolaryngology Unit, Latisana-Palmanova Hospital, Azienda Sanitaria Universitaria Friuli Centrale (ASUFC), Udine, Italy. His research interests focus on rhinology, laryngology, pediatric otolaryngology and sleep medicine.
Dr. Fionda graduated in Medicine and Surgery and subsequently specialized in Radiotherapy at the Catholic University of the Sacred Heart in Rome. He started working in 2016 at Gemelli-ART (Advanced Radiation Therapy) in Rome dealing with special techniques, such as Surface Guided Radiotherapy (SGRT) which uses specific light sources to monitor the patient’s surface during therapy. Dr. Fionda worked with the first hybrid machine installed in Italy that combines modern linear accelerators (LINAC) with the acquisition of magnetic resonance images allowing to follow the movement of the internal organs in real time. He has also gained long experience in interventional radiotherapy (brachytherapy) with both high dose rate (HDR) and pulsed dose rate (PDR).
Dr Fionda is a member of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) and of the European Society for Radiotherapy and Oncology (ESTRO). He is the author of over 100 publications including conference abstracts and research articles on national and international journals, and is adjunct Professor of Radiation Oncology at Saint Camilus International University of Healh Sciences.
Dr. Loperfido graduated in Medicine and Surgery at the University of Siena and subsequently specialized in Otolaryngology at the Catholic University of the Sacred Heart - Gemelli Hospital in Rome. She works at the largest tertiary public hospital in Rome: San Camillo Forlanini Hospital. She has received specific training in rhinology, with special focus on innovative medical treatment with biological drugs for chronic rhinosinusitis with nasal polyps at La Sapienza University in Rome.
Dr. Loperfido is a member of the Italian Society of Otolaryngology and Head and Neck Surgery (SIOeChCF), she is the author of several publications on national and international journals, she is particular active as reviewer and she is currently serving as editorial board member in multiple scientific journals.
Nijiro Nohata, M.D., Ph.D. Principal Scientist of Oncology Science Unit, MSD K.K., Japan. Active member of ASCO, ESMO, JSMO, JCA
1978 -1987; Researcher in the Cancer Cell Chemistry Laboratory, Institute of Experimental and Clinical Medicine, Riga, Latvia.
Professor of Medical Biochemistry and Medical Genetics, University of Latvia, Faculty of Medicine (since 1998). Address: Jelgavas Street 1, Riga LV1004 Latvia. Chief of the Department of Medical Biochemistry (2011).
Leading researcher (since 2011) and Head of the Biochemistry Group, Department of Medicinal Chemistry, Latvian Institute of Organic Synthesis (since 1990).
1995 and 1997 “Red position” of CNRS 1993-1998; Institut Jacques Monod, Université Paris VII, Laboratoire de Biochimie de Différentiation, Paris, France.
Degree of Doctor of Biological Sciences (Dr. habil.), 1992, Institute of Experimental Medicine, St.-Petersburg, Russia. Degree of Candidate of Biological Sciences (Ph. D.), 1984, Cancer Research Centre, Moscow, Russia. Diploma with Distinction in Medical Biophysics, graduated from the Medico-Biological faculty of the 2nd Moscow Medical Institute, Moscow, Russia, 1978.